Low-molecular-weight heparin in patients with advanced cirrhosis-Reference-Cited by-同舟云学术

Low-molecular-weight heparin in patients with advanced cirrhosis

Published:2010-10-20 Issue:1 Volume:31 Page:75-82
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Bechmann Lars P.,Sichau Matthias,Wichert Marc,Gerken Guido,Kröger Knut,Hilgard Philip

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2010.02358.x/fullpdf

Reference33 articles.

1. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group;Samama;N Engl J Med,1999

2. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients;Leizorovicz;Circulation,2004

3. International Consensus Statement (guidelines according to scientific evidence);Prevention and treatment of venous thromboembolism.;Int Angiol,2006

4. An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients;Samama;Thromb J,2006

5. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin;Lehman;Am J Clin Pathol,2006

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-09

2. Direct oral anticoagulants in cirrhosis: Rationale and current evidence;JHEP Reports;2024-08

3. A systematic review of therapeutic enoxaparin dosing in obesity;Journal of Thrombosis and Thrombolysis;2024-02-25

4. Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis;International Journal of Molecular Sciences;2023-08-13

5. Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin;Annals of Pharmacotherapy;2023-07-29